Works matching IS 0284186X AND DT 2022 AND VI 61 AND IP 1


Results: 16
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study.

    Published in:
    Acta Oncologica, 2022, v. 61, n. 1, p. 52, doi. 10.1080/0284186X.2021.1995041
    By:
    • Schmidinger, Manuela;
    • Motzer, Robert J.;
    • Rolland, Frederic;
    • Staehler, Michael;
    • Rink, Michael;
    • Retz, Margitta;
    • Csoszi, Tibor;
    • McCaffrey, John A.;
    • De Giorgi, Ugo;
    • Caserta, Claudia;
    • Duran, Ignacio;
    • Benzaghou, Fawzi;
    • Clary, Douglas O.;
    • Albiges, Laurence;
    • Choueiri, Toni K.;
    • Tannir, Nizar M.
    Publication type:
    Article
    12
    13
    14
    15
    16